Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wiemann

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Fortschritte Der Kieferorthopadie|January 1, 1986
[Orthodontic model analysis using various coordinate measurement technics]H J Schenk, G Fuchs, C Wiemann, et al.
Minerva Ginecologica|February 25, 2005
Chemotherapy for ovarian cancer: an evidence-based approachJ P Geisler, K J Manahan, M C Wiemann
American Journal of Botany|May 12, 2012
Radial wood allocation in Schizolobium parahybaG Bruce Williamson, Michael C Wiemann, James P Geaghan
The Review of Scientific Instruments|July 5, 2012
Deflection gating for time-resolved x-ray magnetic circular dichroism-photoemission electron microscopy using synchrotron radiationC Wiemann, A M Kaiser, S Cramm, et al.
Fortschritte Der Kieferorthopadie|April 1, 1986
[Recommendation for computer-assisted diagnosis in cleft jaw]H J Schenk, C Wiemann, C Ulbrich, et al.
Fortschritte Der Kieferorthopadie|December 1, 1984
[Experimental studies on the effect of ovarian hormones on the development of rat mandibles]M Duncker, F Döcke, U Moldenhauer, et al.
Journal of Autoimmunity|February 1, 1994
Macrogolgin--a new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infectionsH P Seelig, P Schranz, H Schröter, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2002
Joint positive control testing in guinea pig skin sensitization tests. A harmonized approachC Wiemann, K Berthold, A Heusener, et al.
Chest|July 1, 1993
Carmustine toxicity presenting as a lobar infiltrateD L Patterson, M C Wiemann, T H Lee, et al.
Gynecologic Oncology|March 1, 1996
Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovaryJ P Geisler, M C Wiemann, G A Miller, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Fortschritte Der Kieferorthopadie|January 1, 1986
[Orthodontic model analysis using various coordinate measurement technics]H J Schenk, G Fuchs, C Wiemann, et al.
Minerva Ginecologica|February 25, 2005
Chemotherapy for ovarian cancer: an evidence-based approachJ P Geisler, K J Manahan, M C Wiemann
American Journal of Botany|May 12, 2012
Radial wood allocation in Schizolobium parahybaG Bruce Williamson, Michael C Wiemann, James P Geaghan
The Review of Scientific Instruments|July 5, 2012
Deflection gating for time-resolved x-ray magnetic circular dichroism-photoemission electron microscopy using synchrotron radiationC Wiemann, A M Kaiser, S Cramm, et al.
Fortschritte Der Kieferorthopadie|April 1, 1986
[Recommendation for computer-assisted diagnosis in cleft jaw]H J Schenk, C Wiemann, C Ulbrich, et al.
Fortschritte Der Kieferorthopadie|December 1, 1984
[Experimental studies on the effect of ovarian hormones on the development of rat mandibles]M Duncker, F Döcke, U Moldenhauer, et al.
Journal of Autoimmunity|February 1, 1994
Macrogolgin--a new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infectionsH P Seelig, P Schranz, H Schröter, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2002
Joint positive control testing in guinea pig skin sensitization tests. A harmonized approachC Wiemann, K Berthold, A Heusener, et al.
Chest|July 1, 1993
Carmustine toxicity presenting as a lobar infiltrateD L Patterson, M C Wiemann, T H Lee, et al.
Gynecologic Oncology|March 1, 1996
Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovaryJ P Geisler, M C Wiemann, G A Miller, et al.
Pageof 10